Artificial Intelligence in Healthcare Global market

–Forecast to 2027

Artificial Intelligence in Healthcare Global Market estimated to be worth $35.3

billion by 2027

IQ4I Research & Consultancy published a new report on “Artificial intelligence in

Healthcare Global Market – Forecast To 2027” This report analyzes and studies the
overall market, major Drivers & Opportunities, Restraints & Threats in North America,
Europe, Asia-Pacific and Rest of the World.

IQ4I’s Report Contains 68 market data tables and 38 figures spread through 383 pages
and an exhaustive TOC on “Artificial Intelligence in Healthcare Global Market”, [By
Application {Medical diagnosis, drug discovery, precision medicines, clinical trials,
Healthcare Documentation management and other applications (AI guided robotic
surgical procedures and AI-enhanced medical device and pharmaceutical
manufacturing processes)}, by End-Users {Hospitals and Diagnostic Laboratories,
Pharmaceutical companies, Research Institutes and other end-users (Health
insurance companies, medical device and pharmaceutical manufacturers and patients
or individuals in the home-care settings)}, by Region {North America (U.S.), Europe
(U.K.), Asia-Pacific (China) and Rest of the world}].

Artificial intelligence (AI) is a constellation of technologies that enables the machines to

perform the human intelligence characterized tasks like understanding, recognizing,
problem-solving and planning efficiently. The current flurry of AI advancement in the
healthcare industry is attributed to the availability of massive healthcare data, emergence of
the powerful graphics processing units (GPUs) for complex and higher-order computations,
the re-emergence of the deep learning techniques and the shift to fee for value paradigm.
The potential of AI to seamlessly assist and guide the healthcare personnel in arriving at the
accurate, precise and rapid diagnostic or therapeutic conclusions, to improve patient care, to
empower individuals in their self-care, to optimize the various administrative tasks of
healthcare organizations effectively, to humanize and personalize the various healthcare
services, to enhance human ingenuity with precision and speed and to accelerate the drug
discovery and development process efficiently is expected to revolutionize the healthcare
field in the coming years and make it an indispensable part of healthcare ecosystem.

AI in healthcare global market is expected to reach $35,323.5 million by 2027 growing at an

exponential CAGR from 2020 to 2027. Some of the factors such as the gradual transition
from volume to value-based healthcare, the surging need to accelerate and increase the
efficiency of drug discovery and clinical trial processes, advancement of precision medicines
are driving the market growth. Factors like escalation of AI as a medical device, increasing
prevalence of chronic, communicable diseases and escalating geriatric population and the
increasing trend of acquisitions, collaborations, investments in the AI in healthcare market
are further substantiating the enormous growth opportunities of the market.

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Artificial Intelligence in Healthcare Global market

–Forecast to 2027

AI in healthcare market is classified based on the application, end-user and geography.

Based on the application, the market is segmented into Medical diagnosis, drug discovery,
precision medicines, clinical trials, Healthcare Documentation management and others
consisting of AI guided robotic surgical procedures and AI enhanced medical device and
pharmaceutical manufacturing processes. The artificial intelligence in healthcare global end
users market is grouped into Hospitals and Diagnostic Laboratories, Pharmaceutical
companies, Research institutes and other end-users consisting of health insurance
companies, medical device and pharmaceutical manufacturers and patients or individuals in
the home-care settings. The AI in healthcare global market by geography is segmented into
North America, Europe, Asia-Pacific and the Rest of the world (RoW).

The promising future of AI in the healthcare industry is further substantiated in the report
through several IQ4I analyses of the AI associated funding scenario, key AI leveraging
deals, FDA regulatory approvals, regional and country-wise spread of an illustrative set of
healthcare AI start-ups, patent trends and clinical trials. The enormous funding of
~$5,000.51 million raised by the various private sector AI companies during 2019 – 2020 for
the development of innovative AI solutions, for expanding the geographical reach of these
highly efficient solutions and up-scaling of their existing AI solutions, the large number of
existing and emerging AI-based healthcare start-ups across the globe involved in the
development of AI solutions for real world problems, the numerous deals made by the
various kinds of healthcare organizations and pharma companies for leveraging the
disruptive AI technology to improve their operational efficiency, to humanize and
democratize their services and ensure enhanced client satisfaction and the persistently
extending robust AI embedded healthcare solutions pipeline being evaluated through
various stages of development for determining their feasibility all point out to the slow but
pertinacious integration of AI into healthcare industry and that it is all set to transform or
revolutionize the healthcare industry in the near future.

To increase their market reach and to perpetuate their leading position in the market, AI
companies have adopted the strategies of co-developing of innovative AI solutions through
collaborations or partnerships, up-scaling of their AI solutions, launching of novel AI
solutions and acquisitions. The AI in healthcare market is consolidated with the top five
players occupying majority of the market share. Some of the top players are IBM Corp., GE,
Microsoft Corp., Alphabet Inc., Nuance Communications Inc., Intel Corp., Medtronic PLC,
Nvidia Corp., Welltok Inc., Philips N.V. and others.

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Artificial Intelligence in Healthcare Global market

–Forecast to 2027

Reasons for buying this report:

 Artificial intelligence in healthcare global market is projected to reach $35,323.5
million by 2027 growing at a CAGR of 41.7%.
 Identification and analysis of the artificial intelligence in healthcare global market by
identifying various segments by application, end users and geography.
 Revenue forecast of artificial intelligence in healthcare market and strategic analysis
of each sub-segment with respect to segmental growth trends.
 Identification of major market trends, Porter's model, and factors driving and
restraining artificial intelligence in healthcare market growth.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Analysis of the global market share by major players, funding scenario, AI leveraging
key deals, clinical trials, regional spread of AI based healthcare start-ups, patents,
FDA approved Artificial intelligence algorithms of the artificial intelligence in
healthcare market and AI company matrix.
 Revenue forecast of the artificial intelligence in healthcare market with respect to
North America (U.S.), Europe (U.K.), Asia-Pacific (China) and Rest of the World
regions.
 Profiles of major players in the artificial intelligence in healthcare global market and
analysis of their product offerings, financial revenue, business strategies, SWOTs
and market shares.

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Artificial Intelligence in Healthcare Global market

–Forecast to 2027

FIGURE 1

ARTIFICIAL INTELLIGENCE IN HEALTHCARE GLOBAL MARKET

SEGMENTATION

Artificial Intelligence in Healthcare

Global Market

By Application By End-User By Region

NA
Medical Hospitals &
Diagnosis Diagnostic Labs
U.S.
Drug Discovery Pharmaceutical
Companies
EU
Clinical Trials Research
Institutes
U.K.
Precision Other
Medicine End-Users
APAC
Documentation
Management
China
Other
Applications
RoW

IQ4I Research & Consultancy Pvt. Ltd. Page 4